Pediatric Neurology
Paediatric neurology spans infantile spasms to adolescent neurology with major recent therapeutic advances. The session covers SMA gene therapy real-world (Zolgensma 5-year follow-up), nusinersen and risdiplam comparison data, Duchenne therapeutics (Elevidys gene therapy approval and post-approval surveillance), paediatric epilepsy surgery and the new MR-guided laser ablation (Visualase, NeuroBlate), autism spectrum disorder neurobiology and emerging therapeutics, and adolescent transition to adult care. Discussion addresses tuberous sclerosis complex and mTOR inhibitors, Rett syndrome and trofinetide, neonatal seizure management, paediatric MS and AQP4-NMOSD/MOGAD, and emerging neuromodulation for paediatric epilepsy.
- Zolgensma 5-year follow-up
- Elevidys gene therapy
- Pediatric epilepsy surgery
- MR-guided laser ablation
- Trofinetide for Rett syndrome
- TSC and mTOR inhibitors
- Pediatric MS/NMOSD/MOGAD
- Adolescent transition
Explore the full GCNN 2027 program
- 01Stroke & Cerebrovascular Disease
- 02Alzheimer’s & Dementia
- 03Multiple Sclerosis
- 04Parkinson’s & Movement Disorders
- 05Epilepsy
- 06Neuromuscular Disease
- 07Headache Medicine
- 08Neuro-Oncology
- 09Clinical Neuroscience & AI
- 10Spinal Cord Injury
- 11Traumatic Brain Injury
- 12Sleep Disorders
- 13Neuropathic Pain
- 14Cerebellar & Ataxia Disorders
- 15Functional Neurological Disorders
- 17Neuroimmunology
- 18Brain-Computer Interfaces
- 19Migraine
- 20Cluster Headache
- 21Dementia with Lewy Bodies
- 22Frontotemporal Dementia
- 23Huntington Disease
- 24ALS
- 25Tremor & Dystonia
- 26Restless Legs Syndrome
- 27Neuroinfectious Disease
- 28Brain Tumors
- 29Vestibular Disorders
- 30Autonomic Disorders
- 31Functional Imaging
- 32Neuro-Ophthalmology
- 33Neuropsychology
- 34Movement Disorder Surgery
- 35Genetic Counselling